MCID: HMR012
MIFTS: 52

Hemorrhagic Fever

Categories: Rare diseases, Infectious diseases

Aliases & Classifications for Hemorrhagic Fever

MalaCards integrated aliases for Hemorrhagic Fever:

Name: Hemorrhagic Fever 50 52
Hemorrhagic Fevers, Viral 69
Hemorrhagic Fevers 41

Classifications:



External Ids:

ICD10 33 A98.5

Summaries for Hemorrhagic Fever

MedlinePlus : 41 viral hemorrhagic fevers (vhfs) are a group of illnesses caused by four families of viruses. these include the ebola and marburg, lassa fever, and yellow fever viruses. vhfs have common features: they affect many organs, they damage the blood vessels, and they affect the body's ability to regulate itself. some vhfs cause mild disease, but some, like ebola or marburg, cause severe disease and death. vhfs are found around the world. specific diseases are usually limited to areas where the animals that carry them live. for example, lassa fever is limited to rural areas of west africa where rats and mice carry the virus. the risk for travelers is low, but you should avoid visiting areas where there are disease outbreaks. because there are no effective treatments for some of these viral infections, there is concern about their use in bioterrorism. centers for disease control and prevention

MalaCards based summary : Hemorrhagic Fever, also known as hemorrhagic fevers, viral, is related to alkhurma hemorrhagic fever and balkan hemorrhagic fever, and has symptoms including fever and pruritus. An important gene associated with Hemorrhagic Fever is CD209 (CD209 Molecule), and among its related pathways/superpathways are Cytokine Signaling in Immune system and Influenza A. The drugs Benzocaine and Menthol have been mentioned in the context of this disorder. Affiliated tissues include testes, endothelial and t cells, and related phenotypes are homeostasis/metabolism and cardiovascular system

Related Diseases for Hemorrhagic Fever

Diseases in the Hemorrhagic Fever family:

Viral Hemorrhagic Fever

Diseases related to Hemorrhagic Fever via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 458)
id Related Disease Score Top Affiliating Genes
1 alkhurma hemorrhagic fever 34.0 CD40LG IL10 TNF
2 balkan hemorrhagic fever 34.0 CD40LG IL10
3 dengue disease 33.5 IFNG IL10 TNF
4 lujo hemorrhagic fever 33.0 CD40LG F2 F3 SERPINC1
5 hemophagocytic lymphohistiocytosis 30.1 IFNG IL10 IL6 TNF
6 rift valley fever 29.9 ALB IFNG IL6 TNF
7 chlamydia 29.7 CD40LG IFNG
8 typhoid fever 29.1 ALB CD40LG TNF
9 hepatitis b 28.8 B2M IFNG IL10 TNF
10 lymphoma 28.0 ALB CD40LG IFNG IL10 IL6 TNF
11 malaria 27.1 ALB CD40LG F3 HLA-DRB1 IFNG IL10
12 myocardial infarction 26.7 ALB CD40LG F2 F3 IL10 IL6
13 crimean-congo hemorrhagic fever 12.4
14 omsk hemorrhagic fever 12.4
15 argentine hemorrhagic fever 12.4
16 marburg hemorrhagic fever 12.3
17 hemorrhagic fever with renal syndrome 12.3
18 ebola hemorrhagic fever 12.3
19 bolivian hemorrhagic fever 12.3
20 venezuelan hemorrhagic fever 12.3
21 korean hemorrhagic fever 12.2
22 dengue hemorrhagic fever 12.2
23 viral hemorrhagic fever 12.2
24 chapare hemorrhagic fever 12.2
25 brazilian hemorrhagic fever 12.1
26 whitewater arroyo hemorrhagic fever 12.1
27 kyasanur forest disease 11.6
28 lassa fever 11.6
29 nephropathia epidemica 11.1
30 hantavirus pulmonary syndrome 11.1
31 pure autonomic failure 10.9 IL10 TNF
32 acute ackee fruit intoxication 10.8 IL10 TNF
33 multiple familial trichoepithelioma 10.8 IL10 TNF
34 basidiobolomycosis 10.8 IL10 TNF
35 lagophthalmos 10.7 IL10 TNF
36 smarca4-deficient sarcoma of thorax 10.7 IL6 TNF
37 eye accommodation disease 10.7 IFNG IL10
38 biemond syndrome 10.7 HLA-DRB1 TNF
39 migraine with brainstem aura 10.7 HLA-DRB1 TNF
40 type 1 papillary adenoma of the kidney 10.7 IL10 TNF
41 sternal cleft 10.7 IFNG TNF
42 autoimmune polyglandular syndrome type 3 10.7 IFNG TNF
43 argyria 10.7 F2 GPT
44 pancreatitis, hereditary 10.7
45 dengue fever, protection against 10.7
46 capillary leak syndrome 10.7
47 aortic arch interruption 10.7 IL6 TNF
48 cutaneous leishmaniasis 10.7 IL6 TNF
49 congenital dyserythropoietic anemia 10.7 ALB TNF
50 peroneal nerve paralysis 10.6 IL10 IL6

Graphical network of the top 20 diseases related to Hemorrhagic Fever:



Diseases related to Hemorrhagic Fever

Symptoms & Phenotypes for Hemorrhagic Fever

UMLS symptoms related to Hemorrhagic Fever:


fever, pruritus

MGI Mouse Phenotypes related to Hemorrhagic Fever:

44 (show all 13)
id Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.2 SERPINC1 SLC17A5 TNF ALB B2M CD40LG
2 cardiovascular system MP:0005385 10.18 B2M CD40LG F2 F3 IFNG IL10
3 cellular MP:0005384 10.16 ALB B2M CD40LG F3 IFNG IL10
4 hematopoietic system MP:0005397 10.13 B2M CD40LG F2 F3 IFNG IL10
5 immune system MP:0005387 10.09 IFNG IL10 IL6 SERPINC1 TNF B2M
6 mortality/aging MP:0010768 10.06 ALB B2M CD40LG F2 F3 IFNG
7 digestive/alimentary MP:0005381 10.04 ALB B2M F2 IFNG IL10 IL6
8 integument MP:0010771 10.01 B2M CD40LG F2 F3 IFNG IL10
9 liver/biliary system MP:0005370 9.91 ALB B2M IFNG IL10 IL6 SERPINC1
10 nervous system MP:0003631 9.85 IL6 SERPINC1 SLC17A5 TNF B2M CD40LG
11 neoplasm MP:0002006 9.8 ALB B2M F3 IFNG IL10 IL6
12 reproductive system MP:0005389 9.56 B2M CD40LG F2 IFNG IL10 IL6
13 vision/eye MP:0005391 9.17 F3 IFNG IL10 IL6 SERPINC1 SLC17A5

Drugs & Therapeutics for Hemorrhagic Fever

Drugs for Hemorrhagic Fever (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 119)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Benzocaine Approved Phase 4,Phase 1,Phase 2 1994-09-7, 94-09-7 2337
2
Menthol Approved Phase 4 2216-51-5 16666
3
Histamine Approved, Investigational Phase 4 75614-87-8, 51-45-6 774
4
Ketotifen Approved Phase 4 34580-14-8, 34580-13-7 3827
5 tannic acid Approved, Nutraceutical Phase 4,Phase 1,Phase 2
6 Vaccines Phase 4,Phase 2,Phase 3,Phase 1
7 Dermatologic Agents Phase 4,Phase 1,Phase 2
8 Vasoconstrictor Agents Phase 4
9 Anti-Allergic Agents Phase 4
10 Antipruritics Phase 4
11 Histamine Antagonists Phase 4
12 Histamine H1 Antagonists Phase 4
13
Histamine Phosphate Phase 4 51-74-1 65513
14 Neurotransmitter Agents Phase 4
15
Ivermectin Approved, Vet_approved Phase 2, Phase 3 70288-86-7 6474909 46936176
16
Loperamide Approved Phase 2, Phase 3 53179-11-6 3955
17
Vitamin A Approved, Nutraceutical, Vet_approved Phase 3 11103-57-4, 68-26-8 445354
18
Lactitol Investigational Phase 3 585-86-4 3871
19 Pharmaceutical Solutions Phase 3,Phase 2,Phase 1
20 Anti-Infective Agents Phase 2, Phase 3, Phase 1
21 Antiparasitic Agents Phase 2, Phase 3,Phase 1
22 DEET Phase 3
23 Insect Repellents Phase 3
24 Protective Agents Phase 3,Phase 1
25 Antibodies Phase 3,Phase 1,Phase 2
26 Immunoglobulins Phase 3,Phase 1,Phase 2
27 Antibodies, Blocking Phase 3
28 Heptavalent Pneumococcal Conjugate Vaccine Phase 3,Phase 2
29 Krestin Phase 3,Phase 2,Phase 1
30 Vitamins Phase 3,Phase 2
31 Anti-Bacterial Agents Phase 2, Phase 3,Phase 1
32 Iron-Dextran Complex Phase 3
33 Antioxidants Phase 3
34 Micronutrients Phase 3
35 Retinol palmitate Phase 3
36 Trace Elements Phase 3
37 retinol Nutraceutical Phase 3
38
Hydrocortisone Approved, Vet_approved Phase 2 50-23-7 5754 657311
39
Ribavirin Approved Phase 2 36791-04-5 37542
40
Azithromycin Approved Phase 1, Phase 2 83905-01-5 55185 53477736 447043
41
Coal tar Approved Phase 1, Phase 2 8007-45-2
42
Irbesartan Approved, Investigational Phase 1, Phase 2 138402-11-6 3749
43
Sunitinib Approved, Investigational Phase 1, Phase 2 341031-54-7, 557795-19-4 5329102
44
chloroquine Approved, Vet_approved Phase 1, Phase 2 54-05-7 2719
45
Neomycin Approved, Vet_approved Phase 1, Phase 2 1404-04-2 8378
46
Artemether Approved Phase 2 71963-77-4 119380 68911
47
Lumefantrine Approved Phase 2 82186-77-4 6437380
48
Epinephrine Approved, Vet_approved Phase 2,Phase 1 51-43-4 5816
49 Racepinephrine Approved Phase 2,Phase 1
50
Angiotensin II Investigational Phase 1, Phase 2 68521-88-0, 4474-91-3, 11128-99-7 172198 65143

Interventional clinical trials:

(show top 50) (show all 233)

id Name Status NCT ID Phase Drugs
1 High Frequency Ventilation During Off Pump Coronary Artery Bypass Graft (CABG) Completed NCT00863044 Phase 4
2 Open Study of the Duration of Immunity After Vaccination With GamEvac-Combi Recruiting NCT02911415 Phase 4
3 Open Study of the Duration of Immunity After Vaccination With GamEvac Recruiting NCT02911428 Phase 4
4 Ketotifen as a Treatment for Vascular Leakage During Dengue Fever Recruiting NCT02673840 Phase 4 Ketotifen;Placebo
5 International Multicenter Study of the Immunogenicity of Medicinal Product GamEvac-Combi Recruiting NCT03072030 Phase 4
6 Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study) Recruiting NCT02555072 Phase 4
7 Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals Recruiting NCT03132311 Phase 4
8 Immunogenicity and Safety of Fractional Doses of Yellow Fever Vaccines (YEFE) Not yet recruiting NCT02991495 Phase 4
9 Effect of Hypertonic Sodium Lactate on sVCAM-1 Level as Surrogate Marker of Endothelial Capillary Leakage in Pediatric Dengue Shock Syndrome Patients (DSS) Unknown status NCT00966628 Phase 3 Hypertonic sodium lactate;Ringer's lactate
10 Efficacy and Safety of Ivermectin Against Dengue Infection Unknown status NCT02045069 Phase 2, Phase 3 2 days Ivermectin;3 days Ivermectin;Placebo
11 Clinical Evaluation of Insect Repellent and Insecticide Treated Nets in Lao PDR Unknown status NCT00938379 Phase 3 20% deet insect repellent;placebo control
12 STRIVE (Sierra Leone Trial to Introduce a Vaccine Against Ebola) Completed NCT02378753 Phase 2, Phase 3
13 Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia Completed NCT01254422 Phase 3
14 Study to Evalutate Long-term Immunity of Hantavax in High Risk Population of HFRS Completed NCT02360514 Phase 3 Hantavax injection
15 Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlers Completed NCT01411241 Phase 3
16 Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea Completed NCT02342171 Phase 2, Phase 3
17 Study of a Tetravalent Dengue Vaccine in Healthy Adults in Australia Completed NCT01134263 Phase 3
18 Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers Completed NCT01436396 Phase 3
19 Evaluation of the Safety and Immunogenicity of Three Consistency Lots and a High-Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults (V920-012) Completed NCT02503202 Phase 3
20 A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults Completed NCT01466387 Phase 3
21 Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo Recruiting NCT02661464 Phase 3
22 Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo During Implementation of Stages 1 and 2 Recruiting NCT02509494 Phase 3
23 Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine Recruiting NCT02406729 Phase 3
24 Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects Active, not recruiting NCT02992418 Phase 3
25 Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia Active, not recruiting NCT01373281 Phase 3
26 Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America Active, not recruiting NCT01374516 Phase 3
27 Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil® Active, not recruiting NCT02993757 Phase 3
28 Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix® Active, not recruiting NCT02979535 Phase 3
29 The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient. Active, not recruiting NCT01426243 Phase 3
30 Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine. Active, not recruiting NCT02699099 Phase 3
31 Providing Additional Information on the Safety and Effectiveness of an Ebola Vaccine Suspended NCT03161366 Phase 3
32 Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola. Virus Disease (EVD) in Sierra Leone. EASE (EMERGENCY Amiodarone Study Against Ebola) Withdrawn NCT02307591 Phase 2, Phase 3 Best Supportive Care;Best Supportive Care + Amiodarone
33 Chinese and Western Medicine Treatment of Fever Associated With Bleeding Symptoms Unknown status NCT01973855 Phase 2 Western Medicine;TCM and Western Medicine
34 Treatment of Japanese Encephalitis Unknown status NCT00216268 Phase 2 Ribavirin
35 Multiple Treatments for Ebola Virus Disease (EVD) Unknown status NCT02380625 Phase 1, Phase 2 Azithromycin;Sunitinib and Erlotinib;Atorvastatin and Irbesartan
36 The Effect of Chloroquine in the Treatment of Patients With Dengue Unknown status NCT00849602 Phase 1, Phase 2 Placebo;Chloroquine
37 Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever Completed NCT01601613 Phase 2 activated recombinant human factor VII;placebo
38 Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South America Completed NCT01187433 Phase 2
39 A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the Philippines Completed NCT01064141 Phase 2
40 Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the US Completed NCT00617344 Phase 2
41 Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India Completed NCT01550289 Phase 2
42 Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult Subjects Completed NCT00730288 Phase 2
43 Safety and Immunogenicity of Formulations of Dengue Vaccines in Healthy Flavivirus-Naïve Adults Completed NCT00740155 Phase 2
44 Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years Completed NCT00788151 Phase 2
45 Safety and Immunogenicity Study of Rift Valley Fever Vaccine Completed NCT00584194 Phase 2
46 Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America Completed NCT00993447 Phase 2
47 Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore Completed NCT00880893 Phase 2
48 Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects Completed NCT00875524 Phase 2
49 Efficacy and Safety of Dengue Vaccine in Healthy Children Completed NCT00842530 Phase 2
50 Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine Completed NCT01488890 Phase 2

Search NIH Clinical Center for Hemorrhagic Fever

Genetic Tests for Hemorrhagic Fever

Anatomical Context for Hemorrhagic Fever

MalaCards organs/tissues related to Hemorrhagic Fever:

39
Testes, Endothelial, T Cells, Kidney, Liver, Monocytes, Pituitary

Publications for Hemorrhagic Fever

Articles related to Hemorrhagic Fever:

(show top 50) (show all 1808)
id Title Authors Year
1
Generic amplification and next generation sequencing reveal Crimean-Congo hemorrhagic fever virus AP92-like strain and distinct tick phleboviruses in Anatolia, Turkey. ( 28705183 )
2017
2
Crimean-Congo hemorrhagic fever virus nucleocapsid protein has dual RNA binding modes. ( 28922369 )
2017
3
Dengue Hemorrhagic Fever: A State-of-the-Art Review Focused in Pulmonary Involvement. ( 28612239 )
2017
4
Serosurvey for Crimean-Congo hemorrhagic fever virus infections in ruminants in Katanga province, Democratic Republic of the Congo. ( 28712556 )
2017
5
Hemorrhagic fever with renal syndrome caused by Hantaan virus infection in four pregnant Chinese women. ( 28504470 )
2017
6
Combination of RT-PCR and proteomics for the identification of Crimean-Congo hemorrhagic fever virus in ticks. ( 28736753 )
2017
7
A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models. ( 28922426 )
2017
8
Effect of TLR10 (2322A/G, 720A/C, and 992T/A) polymorphisms on the pathogenesis of Crimean Congo hemorrhagic fever disease. ( 28843003 )
2017
9
Molecular detection of Crimean-Congo hemorrhagic fever virus in ticks, Greece, 2012-2014. ( 28920177 )
2017
10
Alkhurma hemorrhagic fever virus. ( 28456648 )
2017
11
Vitamin D serostatus and dengue fever progression to dengue hemorrhagic fever/dengue shock syndrome. ( 28903788 )
2017
12
Performance assessment of the SAPS II and SOFA scoring systems in Hanta virus Hemorrhagic Fever with Renal Syndrome. ( 28804005 )
2017
13
Dengue Hemorrhagic Fever in the Northwest of Mexico: A Two-Decade Analysis. ( 28613285 )
2017
14
Interferon-I^-Driven iNOS: A Molecular Pathway to Terminal Shock in Arenavirus Hemorrhagic Fever. ( 28826838 )
2017
15
Serosurvey of Crimean-Congo Hemorrhagic Fever Virus in Cattle, Mali, West Africa. ( 28719259 )
2017
16
Tetracyclines as a potential antiviral therapy against Crimean Congo hemorrhagic fever virus: Docking and molecular dynamic studies. ( 28709136 )
2017
17
A neonatal death associated with Crimean-Congo hemorrhagic fever (Republic of Kalmykia, Russia, June 2016). ( 28870741 )
2017
18
Spontaneous rectus sheath hematomas in dengue hemorrhagic fever: A case report. ( 28856103 )
2017
19
Convergent immunological solutions to Argentine hemorrhagic fever virus neutralization. ( 28630325 )
2017
20
Absence of an N-Linked Glycosylation Motif in the Glycoprotein of the Live-Attenuated Argentine Hemorrhagic Fever Vaccine, Candid #1, Results in Its Improper Processing, and Reduced Surface Expression. ( 28220142 )
2017
21
Anthropogenically driven environmental changes shift the ecological dynamics of hemorrhagic fever with renal syndrome. ( 28141833 )
2017
22
Lack of association between integrin I+vI^3 gene polymorphisms and hemorrhagic fever with renal syndrome in Han Chinese from Hubei, China. ( 28190175 )
2017
23
Genomic Characterization of Crimean-Congo Hemorrhagic Fever Virus in Hyalomma Tick from Spain, 2014. ( 28836897 )
2017
24
Crimean-Congo hemorrhagic fever virus in ticks collected from livestock in Albania. ( 28827176 )
2017
25
Disposable cartridge platform for rapid detection of viral hemorrhagic fever viruses. ( 28194457 )
2017
26
IL-10 and socs3 Are Predictive Biomarkers of Dengue Hemorrhagic Fever. ( 28827898 )
2017
27
Hantavirus retinitis and concurrent hemorrhagic fever with renal syndrome. ( 28237172 )
2017
28
Serum Cytokine Profiles Differentiating Hemorrhagic Fever with Renal Syndrome and Hantavirus Pulmonary Syndrome. ( 28572804 )
2017
29
Dengue Hemorrhagic Fever: ARare Cause of Acute Liver Failure. ( 28903847 )
2017
30
Hemorrhagic fever with renal syndrome in Albania. Focus on predictors of acute kidney injury in HFRS. ( 28411480 )
2017
31
The influence of climatic factors on the development of hemorrhagic fever with renal syndrome and leptospirosis during the peak season in Korea: an ecologic study. ( 28592316 )
2017
32
A Correlation of the Platelet Count with D-Dimer Levels as an Indicator for Component Therapy in Children with Dengue Hemorrhagic Fever. ( 28596655 )
2017
33
Seroepidemiology and risk factors of Crimean-Congo Hemorrhagic Fever among butchers and slaughterhouse workers in southeastern Iran. ( 28935247 )
2017
34
Infection prevention and control practice for Crimean-Congo hemorrhagic fever-A multi-center cross-sectional survey in Eurasia. ( 28886039 )
2017
35
Molecular pathogenesis of viral hemorrhagic fever. ( 28555386 )
2017
36
Space-time epidemiology of Crimean-Congo hemorrhagic fever (CCHF) in Iran. ( 28943247 )
2017
37
Management dilemmas in a rare case of pituitary apoplexy in the setting of dengue hemorrhagic fever. ( 28217383 )
2017
38
Analysis of hemorrhagic fever with renal syndrome and its pathogenic gene sequence based on geographic information system. ( 28685549 )
2017
39
Identification of broadly neutralizing monoclonal antibodies against Crimean-Congo hemorrhagic fever virus. ( 28842265 )
2017
40
Electron Microscopy of Alkhumra Hemorrhagic Fever Virus. ( 28051359 )
2017
41
Correction: Correction: A Novel Rhabdovirus Associated with Acute Hemorrhagic Fever in Central Africa. ( 28880960 )
2017
42
Crimean Congo hemorrhagic fever among the one-humped camel (Camelus dromedaries) in Central Sudan. ( 28774342 )
2017
43
Crimean-Congo Hemorrhagic Fever Virus Suppresses Innate Immune Responses via a Ubiquitin and ISG15 Specific Protease. ( 28877473 )
2017
44
Differences in Mortality and Clinical Manifestations of Dengue Hemorrhagic Fever in Taiwan in Different Years: A Comparison for Cases in 2014 and 2015 Epidemics. ( 28722609 )
2017
45
Crimean-Congo Hemorrhagic Fever in Spain - New Arrival or Silent Resident? ( 28700846 )
2017
46
Becoming an International Scientist in South Korea: Ho Wang Lee's Research Activity about Epidemic Hemorrhagic Fever. ( 28814703 )
2017
47
Serum cytokine/chemokine profiles in patients with dengue fever (DF) and dengue hemorrhagic fever (FHD) by using protein array. ( 28242509 )
2017
48
Dengue Hemorrhagic Fever in a Child With Early-Onset Fistulizing Crohn Disease Under Infliximab and Azathioprine Treatment. ( 26709910 )
2016
49
Crimean-Congo hemorrhagic fever virus in livestock ticks and animal handler seroprevalence at an abattoir in Ghana. ( 27392037 )
2016
50
Crimean Congo Hemorrhagic Fever: A Looming Threat. ( 28712208 )
2016

Variations for Hemorrhagic Fever

Expression for Hemorrhagic Fever

Search GEO for disease gene expression data for Hemorrhagic Fever.

Pathways for Hemorrhagic Fever

Pathways related to Hemorrhagic Fever according to GeneCards Suite gene sharing:

(show all 37)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.28 B2M CD40LG HLA-DRB1 IFNG IL10 IL6
2
Show member pathways
12.73 CD209 HLA-DRB1 IFNG IL6 TNF
3
Show member pathways
12.69 B2M CD40LG HLA-DRB1 IFNG IL10 IL6
4
Show member pathways
12.57 CD40LG HLA-DRB1 IFNG IL10 TNF
5
Show member pathways
12.53 HLA-DRB1 IFNG IL10 IL6 TNF
6
Show member pathways
12.51 F2 IFNG IL10 IL6 TNF
7 12.44 B2M CD40LG IFNG IL10 TNF
8
Show member pathways
12.33 CD40LG IFNG IL10 IL6 TNF
9
Show member pathways
12.13 CD40LG HLA-DRB1 IFNG IL10 TNF
10
Show member pathways
12.07 IFNG IL10 IL6 TNF
11 11.93 IFNG IL6 TNF
12 11.9 IL10 IL6 TNF
13
Show member pathways
11.89 B2M HLA-DRB1 IFNG
14 11.89 CD209 HLA-DRB1 IFNG IL10 IL6 TNF
15
Show member pathways
11.87 IFNG IL10 IL6 TNF
16 11.83 F3 IL6 TNF
17 11.83 CD209 IFNG IL10 IL6 TNF
18 11.82 HLA-DRB1 IL6 TNF
19 11.79 IFNG IL10 IL6 TNF
20 11.75 HLA-DRB1 IFNG IL6 TNF
21 11.73 IFNG IL10 TNF
22
Show member pathways
11.71 CD40LG IFNG TNF
23 11.7 IL10 IL6 TNF
24 11.62 CD40LG IL10 IL6 TNF
25
Show member pathways
11.6 B2M IFNG TNF
26 11.54 CD209 IFNG IL10 IL6 TNF
27
Show member pathways
11.53 CD40LG IFNG IL6 TNF
28 11.51 IFNG IL6 TNF
29 11.48 IL10 IL6 TNF
30 11.43 IFNG IL6 TNF
31
Show member pathways
11.38 IFNG IL10 TNF
32 11.3 IL10 IL6 TNF
33 11.25 IFNG IL6 TNF
34 11.17 IFNG IL10 IL6 TNF
35 11.16 CD40LG IL10 IL6 TNF
36 11.04 CD40LG IFNG IL10 IL6 TNF
37 10.5 HLA-DRB1 IFNG IL10 IL6 TNF

GO Terms for Hemorrhagic Fever

Cellular components related to Hemorrhagic Fever according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.9 ALB B2M CD209 CD40LG F2 F3
2 cell surface GO:0009986 9.8 B2M CD209 CD40LG F3 HLA-DRB1 TNF
3 extracellular space GO:0005615 9.7 ALB B2M CD40LG F2 F3 GPT
4 endoplasmic reticulum lumen GO:0005788 9.65 ALB B2M F2 IL6 SERPINC1
5 external side of plasma membrane GO:0009897 9.23 B2M CD209 CD40LG F2 HLA-DRB1 IFNG

Biological processes related to Hemorrhagic Fever according to GeneCards Suite gene sharing:

(show all 33)
id Name GO ID Score Top Affiliating Genes
1 response to drug GO:0042493 9.94 B2M IFNG IL10 IL6
2 platelet activation GO:0030168 9.83 CD40LG F2 IL6
3 positive regulation of sequence-specific DNA binding transcription factor activity GO:0051091 9.82 IL10 IL6 TNF
4 positive regulation of protein kinase B signaling GO:0051897 9.79 F3 IL6 TNF
5 interferon-gamma-mediated signaling pathway GO:0060333 9.76 B2M HLA-DRB1 IFNG
6 response to glucocorticoid GO:0051384 9.75 IL10 IL6 TNF
7 positive regulation of T cell proliferation GO:0042102 9.74 CD40LG IFNG IL6
8 humoral immune response GO:0006959 9.71 IFNG IL6 TNF
9 hemostasis GO:0007599 9.7 F2 F3 SERPINC1
10 positive regulation of nitric oxide biosynthetic process GO:0045429 9.67 IFNG IL6 TNF
11 cellular response to lipopolysaccharide GO:0071222 9.67 IFNG IL10 IL6 TNF
12 positive regulation of chemokine production GO:0032722 9.66 IL6 TNF
13 positive regulation of membrane protein ectodomain proteolysis GO:0051044 9.65 IFNG TNF
14 antigen processing and presentation GO:0019882 9.65 CD209 HLA-DRB1 IFNG
15 cellular response to hepatocyte growth factor stimulus GO:0035729 9.64 IL10 IL6
16 response to molecule of bacterial origin GO:0002237 9.63 B2M IL10
17 positive regulation of heterotypic cell-cell adhesion GO:0034116 9.63 IL10 TNF
18 positive regulation of protein import into nucleus, translocation GO:0033160 9.62 IFNG IL6
19 positive regulation of chemokine biosynthetic process GO:0045080 9.61 IFNG TNF
20 negative regulation of lipid storage GO:0010888 9.61 IL6 TNF
21 endothelial cell apoptotic process GO:0072577 9.6 IL10 TNF
22 positive regulation of MHC class II biosynthetic process GO:0045348 9.59 IFNG IL10
23 negative regulation of cytokine secretion involved in immune response GO:0002740 9.56 IL10 TNF
24 epithelial cell proliferation involved in salivary gland morphogenesis GO:0060664 9.55 IL6 TNF
25 cellular protein metabolic process GO:0044267 9.55 ALB B2M F2 IL6 SERPINC1
26 regulation of immunoglobulin secretion GO:0051023 9.51 CD40LG TNF
27 receptor biosynthetic process GO:0032800 9.46 IL10 TNF
28 neutrophil apoptotic process GO:0001781 9.43 IFNG IL6
29 defense response to protozoan GO:0042832 9.43 IFNG IL10 IL6
30 positive regulation of calcidiol 1-monooxygenase activity GO:0060559 9.4 IFNG TNF
31 positive regulation of vitamin D biosynthetic process GO:0060557 9.32 IFNG TNF
32 immune response GO:0006955 9.17 B2M CD40LG HLA-DRB1 IFNG IL10 IL6
33 negative regulation of growth of symbiont in host GO:0044130 9.13 IFNG IL10 TNF

Molecular functions related to Hemorrhagic Fever according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 protease binding GO:0002020 9.13 F3 SERPINC1 TNF
2 cytokine activity GO:0005125 9.02 CD40LG IFNG IL10 IL6 TNF

Sources for Hemorrhagic Fever

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....